Steven Gary Richardson - Net Worth and Insider Trading

Steven Gary Richardson Net Worth

The estimated net worth of Steven Gary Richardson is at least $2 Million dollars as of 2024-09-20. Steven Gary Richardson is the Director of Travere Therapeutics Inc and owns about 129,165 shares of Travere Therapeutics Inc (TVTX) stock worth over $2 Million. Details can be seen in Steven Gary Richardson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Gary Richardson has not made any transactions after 2014-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven Gary Richardson

To

Steven Gary Richardson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Gary Richardson owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .

Click here to see the complete history of Steven Gary Richardson’s form 4 insider trades.

Insider Ownership Summary of Steven Gary Richardson

Ticker Comapny Transaction Date Type of Owner
TVTX Travere Therapeutics Inc 2014-11-21 director

Steven Gary Richardson Latest Holdings Summary

Steven Gary Richardson currently owns a total of 1 stock. Steven Gary Richardson owns 129,165 shares of Travere Therapeutics Inc (TVTX) as of November 21, 2014, with a value of $2 Million.

Latest Holdings of Steven Gary Richardson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TVTX Travere Therapeutics Inc 2014-11-21 129,165 15.06 1,945,225

Holding Weightings of Steven Gary Richardson


Steven Gary Richardson Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Gary Richardson has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the acquisition of 6,100 shares on November 21, 2014, which cost Steven Gary Richardson around $51,118.

Insider Trading History of Steven Gary Richardson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Gary Richardson Trading Performance

GuruFocus tracks the stock performance after each of Steven Gary Richardson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Gary Richardson is 75.97%. GuruFocus also compares Steven Gary Richardson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Gary Richardson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven Gary Richardson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven Gary Richardson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 67.6 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 67.25 LIMIT LIMIT LIMIT LIMIT LIMIT

Steven Gary Richardson Ownership Network

Ownership Network List of Steven Gary Richardson

No Data

Ownership Network Relation of Steven Gary Richardson

Insider Network Chart

Steven Gary Richardson Owned Company Details

What does Travere Therapeutics Inc do?

Who are the key executives at Travere Therapeutics Inc?

Steven Gary Richardson is the director of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , director & Chief Executive Officer Eric M Dube , and Chief Financial Officer Christopher R. Cline .

Travere Therapeutics Inc (TVTX) Insider Trades Summary

Over the past 18 months, Steven Gary Richardson made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,870 shares made by Christopher R. Cline , a net sale of 9,089 shares made by Elizabeth E Reed , and a net sale of 9,089 shares made by William E. Rote .

In summary, during the past 3 months, insiders sold 37,969 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 37,969 shares. During the past 18 months, 70,194 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 70,194 shares.

Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Travere Therapeutics Inc Insider Transactions

No Available Data

Steven Gary Richardson Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Gary Richardson. You might contact Steven Gary Richardson via mailing address: 117 West 17th Street, Apt 6a, New York Ny 10011.

Discussions on Steven Gary Richardson

No discussions yet.